Pfizer Urges U.S. Congress To Address Threats Posed By Indian Patent System
This article was originally published in The Pink Sheet Daily
Executive Summary
Pfizer waged a war of words against the Indian patent system, speaking to U.S. Congress on behalf of companies impacted by India’s recent IP policies.